期刊文献+

miR-206及Bcl-2蛋白在非小细胞肺癌中的表达及意义 被引量:6

Expression and significance of mi R-206 and Bcl-2 in non small cell lung cancer
原文传递
导出
摘要 目的探讨mi R-206及Bcl-2蛋白在非小细胞肺癌(NSCLC)的表达,以及抑制或过表达mi R-206对Bcl-2蛋白表达的影响。方法实时定量PCR方法检测NSCLC组织mi R-206的表达水平,Western blot方法检测NSCLC组织Bcl-2蛋白表达;将mi R-206 inhibitors及mi R-206 mimics转染至A549细胞,通过CCK-8法测定A549细胞增殖能力的变化,Western blot方法检测转染后Bcl-2蛋白表达变化。结果 mi R-206在非小细胞肺癌组织中的表达量较癌旁组织明显降低(<0.01),Bcl-2蛋白在癌组织中较癌旁组织表达明显增高(<0.05);转染mi R-206 inhibitor的细胞增殖能力与对照组相比显著升高,细胞内Bcl-2蛋白水平亦明显升高(<0.05),转染mi R-206 mimics的细胞增殖能力与对照组相比显著降低,细胞内Bcl-2蛋白水平亦明显降低(<0.05)。结论mi R-206在NSCLC组织中低表达,mi R-206抑制能够促进A549细胞增殖和Bcl-2蛋白表达。 Objective To study the expressions of mi R-206 and Bcl-2 proteins in non small cell lung cancer(NSCLC) to explore the effect of inhibitors or mimics of mi R-206 on the expression of Bcl-2 and proliferation of A549 cells. Methods The expression of mi R-206 m RNA in NSCLC tissues was detected by Real-time quantitative PCR, the expression of Bcl-2 protein was detected by Western blot. A549 cells proliferation was measured by CCK-8 kit and Bcl-2 expression was detectd by Western blot after mi R-206 inhibitor or mi R-206 mimics was transfected into A549 cells. Results The expression level of mi R-206 was significantly decreased in non small cell lung cancer than in normal tissues(P〈0.01), but higher for Bcl-2 protein(P〈0.05). The proliferation rate of A549 cells and the expression level of Bcl-2 protein in A549 cells were increased significantly after mi R-206 inhibitor was transfected(P〈0.05), but decreased significantly after mi R-206 mimics was transfected(P〈0.05). Conclusion The expression of mi R-206 was decreased in NSCLC, and mi R-206 mimics can suppress the proliferation of A549 cells and downregulate Bcl-2 expression.
作者 赵建 刘建亮
出处 《解剖科学进展》 CAS 2014年第6期555-558,共4页 Progress of Anatomical Sciences
基金 辽宁省科技攻关项目(No.2013225021)
关键词 非小细胞肺癌miR-206 BCL-2 A549细胞 转染 non small cell lung mi R-206 Bcl-2 A549 cell transfection
  • 相关文献

参考文献1

二级参考文献25

  • 1Renyi-Vamos F, Tovari J, Fillinger J, Timar J, Paku S, Kenessey Ⅰ and Gyula Ostoros, et al. Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non- small cell lung cancer. Clin Cancer Res 2005, 11: 7344 -7353.
  • 2Al-Rawi MA, Mansel RE and Jiang WG. Lymphangiogenesis and its role in cancer. Histol Histopathol 2005, 20: 283-298.
  • 3Inoue A, Moriya H, Katada N, Tanabe S, Kobayashi N, Watanabe M and Okayasu I, et al. Intratumoral lymphangiogenesis of esophageal squamous cell carcinoma and relationship with regulatory factors and prognosis. Pathol Int 2008, 58:611- 619.
  • 4Jackson DG. New molecular markers for the study of tumor lymphangiogenesis. Anticancer Res 2001, 21: 4279-4283.
  • 5Da MX, Wu Z and Tian HW. Tumor lymphangiogenesis and lymphangiogenic growth factors. Arch Med Res 2008, 39:365- 372.
  • 6Cao Y and Zhong W. Tumor-derived lymphangiogenic factors and lymphatic metastasis. Biomed Pharmacother 2007, 61:534 -539.
  • 7SU JL, Chen PS, Chien MH, Chen PB, Chen YH, Lai CC and Hung MC, et al. Further evidence for expression and function of the VEGF-C/VEGFR-3 axis in cancer cells. Cancer Cell 2008, 13: 557- 560.
  • 8Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB and Lipsky PE. Cyclooxygenase in biology and disease. FASEB J 1998, 12:1063- 1073.
  • 9Williams CS, Mann M and DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999, 18: 7908 -7916.
  • 10Zha S, Yegnasubramanian V, Nelson WG, Isaacs WB and De Matzo AM. Cyclooxygenases in cancer: progress and perspective. Cancer Lett 2004, 215:1 -20.

共引文献33

同被引文献44

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部